Clinical Implications of Genomic Profiles in Metastatic Breast Cancer With a Focus on TP53 and PIK3CA, the Most Frequently Mutated Genes

Oncotarget - United States
doi 10.18632/oncotarget.15881
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Metastatic Breast Cancer: Focus on Capecitabine

Clinical Medicine Reviews in Oncology
2010English

Clinical Implications of Germline Mutations in Breast Cancer Genes: RECQL

Breast Cancer Research and Treatment
Cancer ResearchOncology
2019English

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Different Associations of Tumor PIK3CA Mutations and Clinical Outcomes According to Aspirin Use Among Women With Metastatic Hormone Receptor Positive Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Excision of the Primary Tumour in Patients With Metastatic Breast Cancer: A Clinical Dilemma

Current Oncology
Oncology
2012English

Genomic Analysis of Inherited Breast Cancer Among Palestinian Women: Genetic Heterogeneity and a Founder Mutation in TP53

International Journal of Cancer
Cancer ResearchOncology
2017English

Colorectal Cancer Genomic Biomarkers in the Clinical Management of Patients With Metastatic Colorectal Carcinoma

2020English

High-Throughput Genomic Technology in Research and Clinical Management of Breast Cancer. Molecular Signatures of Progression From Benign Epithelium to Metastatic Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2006English

Prognostic Value of KRAS/TP53/PIK3CA in Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy